BM Bureau, Dec 2 : Amid the stiff competition across the globe to manufacture Covid vaccine on Wednesday Britain has given its approval to Pfizer NSE 2.34 %’s COVID-19 vaccine . The vaccine is expected to reach ‘ the most vulnerable people’ by next week, an official press release said. Thus Britain has jumped ahead of the United States and Europe to become arguably the first country to formally endorse the vaccine.
Reports said that Prime Minister Boris Johnson has proudly announced it as a global win terming it as a ray of hope in the otherwise hopeless and gloomy situation where about 1.5 million people have lost their lives across the globe due to the dreaded pandemic leaving the global economy in shambles.
According to information released Great Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted emergency use approval to the Pfizer-Biotech vaccine, which they say is 95% effective in preventing illness, in record time – just 23 days since Pfizer published the first data from its final stage clinical trial.
“It’s fantastic,” Johnson said. “The vaccine will begin to be made available across the UK from next week. It’s the protection of vaccines that will ultimately allow us to reclaim our lives,” Prime Minister Johnson tweeted.
The world’s big powers have been racing for a vaccine for months in an attempt to be first to begin the long road to recovery.
Its almost a year since the novel corona virus emerged in Wuhan, China, and the vaccine has come as a triumph for science, Pfizer boss Albert Bourla and his German biotechnology partner BioNTech.
…..





















